2021-01-11,Karyopharm Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Total Revenues and Provides Commercial Update
2021-01-04,Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021-01-04,Karyopharm to Present at 39th Annual J.P. Morgan Healthcare Conference
2021-01-03,Antengene Submits NDA for ATG-010 (Selinexor) in South Korea for rrMM and rrDLBCL
2020-12-21,Karyopharm's (KPTI) Xpovio Gets FDA Nod for Second-Line Myeloma
2020-12-20,"Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy"
2020-12-18,"KARYOPHARM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. - KPTI"
2020-12-18,Is KPTI A Good Stock To Buy According To Hedge Funds?
2020-12-18,Karyopharm Announces FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
2020-12-15,"Karyopharm Appoints Michael Mano as Senior Vice President, General Counsel and Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"
2020-12-14,Can You Imagine How Karyopharm Therapeutics' (NASDAQ:KPTI) Shareholders Feel About The 66% Share Price Increase?
2020-12-11,Karyopharm Announces National Comprehensive Cancer Network® Adds Three XPOVIO® (selinexor) Treatment Regimens to Its Clinical Practice Guidelines in Oncology for Multiple Myeloma
2020-12-07,Karyopharm Announces Presentation of New XPOVIO® (Selinexor) Data in Patients with Acute Myeloid Leukemia at the American Society of Hematology 2020 Annual Meeting
2020-12-07,Karyopharm Presents XPOVIO® (Selinexor) Data in Multiple Myeloma and Diffuse Large-B-Cell Lymphoma at the American Society of Hematology 2020 Annual Meeting
2020-12-01,Karyopharm Announces Investor and Analyst Event at the American Society of Hematology 2020 Annual Meeting
2020-12-01,Karyopharm Expands Board of Directors and Executive Leadership Team and Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-11-30,Wall Street Analysts See These 4 Stocks As Winners Moving Into December
2020-11-25,"The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback"
2020-11-25,Karyopharm Announces Ongoing Phase 3 SIENDO Study of XPOVIO® (Selinexor) in Patients with Endometrial Cancer Passes Planned Interim Futility Analysis: Data and Safety Monitoring Board Recommends the Study Should Proceed as Planned Without Any Modifications
2020-11-20,Karyopharm Reports Positive Phase 3 SEAL Data in Oral Presentation at The Connective Tissue Oncology Society 2020 Annual Meeting
2020-11-12,Karyopharm Announces Publication of XPOVIO® (Selinexor) Phase 3 BOSTON Study Results in The Lancet
2020-11-10,Karyopharm to Participate at Jefferies 2020 Virtual London Healthcare Conference
2020-11-04,Karyopharm Announces XPOVIO® (Selinexor) Clinical Data to be Presented at the American Society of Hematology 2020 Annual Meeting
2020-11-03,Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-11-03,"The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure"
2020-11-02,Karyopharm Therapeutics Inc (KPTI) Q3 2020 Earnings Call Transcript
2020-11-02,"Karyopharm Therapeutics (KPTI) Reports Q3 Loss, Lags Revenue Estimates"
2020-11-02,Karyopharm Therapeutics: Q3 Earnings Insights
2020-11-02,Karyopharm Reports Third Quarter 2020 Financial Results and Highlights Recent Company Progress
2020-11-02,Karyopharm Announces Phase 3 SEAL Study Meets Primary Endpoint with Significant Increase in Progression-Free Survival in Patients with Unresectable Dedifferentiated Liposarcoma
2020-11-02,"Karyopharm Therapeutics, Inc. to Host Earnings Call"
2020-10-29,When Will Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Breakeven?
2020-10-26,Earnings Preview: Karyopharm Therapeutics (KPTI) Q3 Earnings Expected to Decline
2020-10-26,"Karyopharm to Report Third Quarter 2020 Financial Results on November 2, 2020"
2020-10-20,Karyopharm Therapeutics Selects MediSpend's Transparency Solution
2020-10-19,Replimune Appoints Tanya Lewis to the Board of Directors
2020-10-06,Karyopharm Therapeutics Inc (KPTI): Hedge Fund Sentiment Unchanged
2020-10-06,Karyopharm Announces Selinexor Clinical Data to be Presented at the International Society for Influenza and Other Respiratory Virus Diseases Antiviral Group Virtual Conference on Therapeutics for COVID-19
2020-10-01,Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-09-14,How Should Investors React To Karyopharm Therapeutics' (NASDAQ:KPTI) CEO Pay?
2020-09-14,Karyopharm Announces XPOVIO® (selinexor) Clinical Data to be Presented at European Society for Medical Oncology Virtual Congress 2020
2020-09-11,Implied Volatility Surging for Karyopharm Therapeutics (KPTI) Stock Options
2020-09-02,Karyopharm Announces September 2020 Virtual Investor Conference Participation
2020-09-01,Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-08-31,Karyopharm Therapeutics Appoints Christy J. Oliger to its Board of Directors
2020-08-21,"Karyopharm's Founder, Sharon Shacham, PhD, Selected as a Finalist for the EY Entrepreneur Of The Year® 2020 Award"
2020-08-10,Kaskela Law LLC Announces Investigation of Karyopharm Therapeutics Inc. (KPTI) and Encourages Long-Term Stockholders to Contact the Firm
2020-08-04,Karyopharm Therapeutics Inc (KPTI) Q2 2020 Earnings Call Transcript
2020-08-04,"Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-04,Karyopharm Reports Second Quarter 2020 Financial Results and Highlights Recent Company Progress
2020-08-03,Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-07-29,Top Small Cap Stocks for August 2020
2020-07-29,Does Karyopharm Therapeutics (NASDAQ:KPTI) Have A Healthy Balance Sheet?
2020-07-28,Karyopharm Therapeutics (KPTI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
2020-07-28,"Karyopharm to Report Second Quarter 2020 Financial Results on August 4, 2020"
2020-07-27,Were Hedge Funds Right About Souring On Karyopharm Therapeutics Inc (KPTI)?
2020-07-20,U.S. Food and Drug Administration Accepts Karyopharms Supplemental New Drug Application for XPOVIO&#174; (selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Line of Therapy
2020-07-17,Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO&#174; (selinexor) Research
2020-07-14,Karyopharm Announces Preliminary Unaudited Second Quarter Product Sales for XPOVIO® (selinexor)
2020-07-01,Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-06-24,Karyopharm Announces Publication of XPOVIO® (Selinexor) Phase 2b SADAL Study Results in The Lancet Haematology
2020-06-23,Karyopharm's Xpovio Gets FDA Accelerated Approval for DLBCL
2020-06-22,Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
2020-06-21,"The Week Ahead In Biotech: Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA Decisions"
2020-06-18,Karyopharm Therapeutics Inc (KPTI): Hedge Funds Taking Some Chips Off The Table
2020-06-12,Edited Transcript of KPTI earnings conference call or presentation 5-May-20 12:30pm GMT
2020-06-12,Karyopharm Presents XPOVIO® (selinexor) and Eltanexor Data at the European Hematology Association 2020 Virtual Annual Meeting
2020-06-10,Karyopharm Starts Dosing in Selinexor Study for Glioblastoma
2020-06-09,Karyopharm Announces Dosing of First Patient in a Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Patients with Newly Diagnosed or Recurrent Glioblastoma
2020-06-03,Are Options Traders Betting on a Big Move in Karyopharm Therapeutics (KPTI) Stock?
2020-06-01,Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-05-29,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant"
2020-05-28,Karyopharm Reports Positive Phase 3 BOSTON Data in Oral Presentation at the American Society of Clinical Oncology 2020 Virtual Scientific Program
2020-05-26,Karyopharm to Participate at Jefferies Virtual Healthcare Conference
2020-05-26,Karyopharm Announces Investor Conference Call to Discuss Phase 3 BOSTON Data To Be Presented at the American Society of Clinical Oncology 2020 Virtual Scientific Program
2020-05-20,Karyopharm Submits Supplemental New Drug Application to FDA for XPOVIO® (selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Line of Therapy
2020-05-13,"Karyopharm Donates 60,000 Medical Masks Across Massachusetts and the United States in Partnership with Family Reach, Myeloma Crowd and The Leukemia & Lymphoma Society"
2020-05-12,Karyopharm to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference
2020-05-06,Things Look Grim For Karyopharm Therapeutics Inc. (NASDAQ:KPTI) After Today's Downgrade
2020-05-05,Were Hedge Funds Right About Karyopharm Therapeutics  Inc (KPTI)?
2020-05-05,Karyopharm Therapeutics Inc (KPTI) Q1 2020 Earnings Call Transcript
2020-05-05,"Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Misses Revenue Estimates"
2020-05-05,Recap: Karyopharm Therapeutics Q1 Earnings
2020-05-05,Karyopharm Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress
2020-05-04,Why Karyopharm (KPTI) Might Surprise This Earnings Season
2020-05-01,Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-04-30,PROMETRIKA and Karyopharm: Partners in Global COVID-19 Trial
2020-04-30,Top Ranked Momentum Stocks to Buy for April 30th
2020-04-29,Karyopharm Announces Data from Phase 3 BOSTON Study Selected for Late-Breaking Oral Presentation at the American Society of Clinical Oncology 2020 Virtual Scientific Program
2020-04-29,Should You Buy Stock Now in This New Coronavirus Drug Developer?
2020-04-28,"Karyopharm to Report First Quarter 2020 Financial Results on May 5, 2020"
2020-04-27,What Makes Karyopharm Therapeutics (KPTI) a Strong Momentum Stock: Buy Now?
2020-04-22,Karyopharm (KPTI) Bulls Find More Reasons to Smile
2020-04-22,Precision For Medicine Partners With Karyopharm Therapeutics To Initiate New Global Clinical Trial To Treat Patients With COVID-19
2020-04-22,Could a cancer drug treat coronavirus? Norton Healthcare joins global trial
2020-04-21,Karyopharm Starts Dosing With Selinexor for Coronavirus Infection
2020-04-20,Karyopharm Therapeutics Inc. (NASDAQ:KPTI): What Does Its Beta Value Mean For Your Portfolio?
2020-04-20,Karyopharm Announces Dosing of First Patient in Randomized Study Evaluating Low Dose Selinexor in Patients with Severe COVID-19
2020-04-07,Karyopharm to Evaluate Low Dose Selinexor as a Potential Treatment for Hospitalized Patients with COVID-19
2020-04-01,Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
